Palisade Bio Inc (PALI)
6.30
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.30
0.00 (0.00%)
After-Hours: 20:00
Palisade Bio Accounts Payable (Quarterly): 0.548M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.548M |
| December 31, 2023 | 0.864M |
| September 30, 2023 | 1.307M |
| June 30, 2023 | 1.291M |
| March 31, 2023 | 0.779M |
| December 31, 2022 | 1.828M |
| September 30, 2022 | 2.207M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.821M |
| March 31, 2022 | 1.546M |
| December 31, 2021 | 1.518M |
| September 30, 2021 | 1.729M |
| June 30, 2021 | 1.607M |
| December 31, 2020 | 3.555M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.548M
Minimum
Mar 2024
3.555M
Maximum
Dec 2020
1.585M
Average
1.546M
Median
Mar 2022
Accounts Payable (Quarterly) Benchmarks
| TG Therapeutics Inc | -- |
| Protagenic Therapeutics Inc | 0.1138M |
| Bio-Path Holdings Inc | 0.457M |
| Jaguar Health Inc | 3.32M |
| Finch Therapeutics Group Inc | 0.047M |